GlobalData, a publicly owned company founded in 2010 and headquartered in the UK, provides information services. Employing approximately 2380 people, the firm specializes in market research, focusing on the analysis and provision of market sizing data.
GlobalData analysts predict recessions in many developed markets before the end of 2022, impacting inflation through reduced labor costs and consumer demand. Separately, GlobalData reported that the American medicines regulator approved three new treatments for hereditary angioedema in 2025, increasing the total number of marketed drugs for this rare disease in the USA to eleven. A GlobalData report on tariffs, released recently, indicates that 37% of 444 surveyed businesses expressed significantly increased concern about tariffs compared to six months prior. This represents a slowdown from the mid-50% range observed since April.
Subscribe for full access to GlobalData's products in full detail
Subscribe for full access to GlobalData's revenue in full detail
Subscribe for full access to GlobalData's products in full detail 
